Promising progression-free survival for patients low and intermediate grade lymphoid malignancies after nonmyeloablative umbilical cord blood transplantation.
about
Umbilical cord blood transplantation for the treatment of hematologic malignanciesNonmyeloablative allogeneic stem cell transplantation for non-hodgkin lymphomaDouble umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis.Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donor.Reduced intensity allogeneic haematopoietic cell transplantation for chronic lymphocytic leukaemia: related donor and umbilical cord allografting.Unrelated umbilical cord blood transplantation and immune reconstitution.Impact of disease status and stem cell source on the results of reduced intensity conditioning transplant for Hodgkin's lymphoma: a retrospective study from the French Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).Allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma: a systematic review and meta-analysis.Alternative donor hematopoietic stem cell transplantation for mature lymphoid malignancies after reduced-intensity conditioning regimen: similar outcomes with umbilical cord blood and unrelated donor peripheral blood.Future of cord blood for oncology uses.Double umbilical cord blood transplant: more than a cell dose?Current status of allogeneic transplantation for aggressive non-Hodgkin lymphoma.Unrelated and alternative donor allogeneic stem cell transplant in patients with relapsed or refractory Hodgkin lymphoma: a systematic review.Umbilical cord blood transplantation in adults with advanced hodgkin's disease: high incidence of post-transplant lymphoproliferative disease.Fourth complete remission with immunosuppression withdrawal and irinotecan after both autologous and allogeneic transplants for diffuse large B cell lymphoma.
P2860
Q26820829-F6E1F1CB-1370-4D1F-AB29-6F093635F2C8Q26999011-7DE1FEC5-AE08-43FE-8210-2A90F5DC57FCQ34451427-803A4A9C-9C62-4386-87F4-64F5249EFBEBQ35108791-80E7E921-F2D6-4A23-B3A5-D38916251F1FQ36092009-6B85C37C-A6C1-4352-9CC7-F45C4227A4CBQ36934304-F35BDC47-4289-4732-9117-C9C2E4E541FEQ37144910-0732F4C8-D3E3-49FD-B071-62E84863D972Q37388718-DF8375D1-C381-4968-BB54-2D4F40B7145BQ37552077-7805323B-DFA6-4FE6-8E0A-6386DA5F12C2Q37607977-986BBFAC-F9F7-4239-B729-DA3CA7D66B42Q37724186-E6126212-9640-4E6A-83F1-B18E06A04063Q37938531-671AF084-C905-4558-BFDD-A831A3ADAF07Q38105131-B51F4920-754A-42DC-ABFF-507F905749FAQ41353081-02425D75-9D48-42E7-8215-4C5887B07C7FQ45918039-EEA2808A-B859-4DCF-8AE7-7E84E2C55766
P2860
Promising progression-free survival for patients low and intermediate grade lymphoid malignancies after nonmyeloablative umbilical cord blood transplantation.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Promising progression-free sur ...... al cord blood transplantation.
@ast
Promising progression-free sur ...... al cord blood transplantation.
@en
type
label
Promising progression-free sur ...... al cord blood transplantation.
@ast
Promising progression-free sur ...... al cord blood transplantation.
@en
prefLabel
Promising progression-free sur ...... al cord blood transplantation.
@ast
Promising progression-free sur ...... al cord blood transplantation.
@en
P2093
P2860
P1476
Promising progression-free sur ...... al cord blood transplantation.
@en
P2093
Brian McClune
Claudio G Brunstein
Daniel J Weisdorf
Jeffrey S Miller
John E Wagner
Linda J Burns
Marcie Tomblyn
Navneet Majhail
Philip B McGlave
P2860
P304
P356
10.1016/J.BBMT.2008.11.013
P577
2009-02-01T00:00:00Z